Evidence map›Paper›PMID 35690233›Full record

ArticleMicrobial pathogenesis2022

Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran.

Mona Sadat Larijani, Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Mohammad Banifazl, Anahita Bavand, Afsaneh Karami, Fatemeh Asgari Shokooh, Amitis Ramezani

Open access · greenAbstract read
In one paragraph

Article in Microbial pathogenesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mona Sadat LarijaniClinical Research Dept., Pasteur Institute of Iran, Tehran, Iran. Electronic address: mona.sadat@gmail.com.
Fatemeh AshrafianClinical Research Dept., Pasteur Institute of Iran, Tehran, Iran. Electronic address: fatemeh.ashrafian24@gmail.com.
Fahimeh Bagheri AmiriDepartment of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran. Electronic address: drop.dr.bagheri@gmail.com.
Mohammad BanifazlIranian Society for Support of Patients with Infectious Disease, Tehran, Iran. Electronic address: mohammadbanifazl@aol.com.
Anahita BavandClinical Research Dept., Pasteur Institute of Iran, Tehran, Iran. Electronic address: anahita.bavand@gmail.com.
Afsaneh KaramiDepartment of Infectious Disease, Zanjan University of Medical Sciences, Zanjan, Iran. Electronic address: dr.akarami@yahoo.com.
Fatemeh Asgari ShokoohClinical Research Dept., Pasteur Institute of Iran, Tehran, Iran. Electronic address: shokooh.f4973@gmail.com.
Amitis RamezaniClinical Research Dept., Pasteur Institute of Iran, Tehran, Iran. Electronic address: amitisramezani@hotmail.com.
Pasteur Institute of Iran · IRIranian Center for Quantum Technologies · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence and variety complaints of COVID-19 cases in a long term have been investigated in recent studies. The symptoms over the time are various and unpredictable which may persist several weeks after full recovery. The importance of long-COVID-19 manifestations includes its effect on the recovered cases which requires a rational management based on an accurate guideline to handle post-acute COVID-19 state. The aim of this study was to evaluate the incidence of post-acute COVID-19 syndrome and to identify the associated risk factors as well as to compare new and persistent symptoms at different post-acute phases. Totally 254 individuals from Pasteur Institute of Iran (or/and their relatives) were investigated who had a previously confirmed COVID-19 PCR test. The long-term manifestations of the virus were categorized through a time window as acute, ongoing, post-COVID and persistent phases and the individuals were assessed by the face-to-face or the phone call interview according to their complaints. The data were then statistically analyzed to determine the frequency of the symptoms and also the associated factors in which a p value < 0.05 was considered significant. Except a small asymptotic group of five, 249 cases progressed the symptoms to acute phase among which 64.1% reported at least one symptom in post-acute phase. Neurological sequelae were found as the most frequent symptom (91.6%). Furthermore, there was a significant association between the underlying diseases, age and acute phase symptoms to the post-acute phase syndrome susceptibility (p < 0.05). In conclusion, the increasing number of the reports and studies on long COVID-19 which can hugely affect the life quality should be more investigated and explored in terms of the pathophysiology to achieve appropriate treatments in time. The clusters of symptoms, specially a combination of neurological signs, presenting over months after the recovery impose a huge difficulty to the recovered population.

Indexed as

COVID-19HumansIranPost-Acute COVID-19 SyndromeProspective StudiesRisk FactorsChronicIranLong COVID-19ManifestationPersistent SARS-CoV-2Post-acute

Identifiers

PMID35690233
PMCPMC9176176
OpenAlexW4282937106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.